Separated pharmaceutical registration system should be limitedly applied.

Published: 2006-01-20 06:56:00

Updated: 2006-01-20 06:56:00

The pharmaceutical industry took a cautious position on the amendment of the pharmaceutical affairs act covering the separated registration system applicable to the pharmaceutical business and products of the new chemical and BT drugs in fear of problems arising from the drug safety and market in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK